Beyond Screening - Understanding the Core Deficits and Diagnosis of FASD

Last modified by Doug Maynard on 2013/04/29 17:08

Synopsis

This webinar is an extension of our webinar series on screening tools for FASD.  We will be welcoming speakers from the  CN-CYR and the NeuroDevNet communities to help bring some of the latest information on this important subject.  Screening for FASD can be an important tool to help identify children that may benefit from further diagnostic investigation.  This webinar will provide a high level overview of the core deficits that define FASD, and will walk through some of the diagnostic options available to clinicians today.  

NeuroDevNet is the first trans-Canada initiative dedicated to studying children’s brain development from both basic science and clinical perspectives. NeuroDevNet’s FASD team is engaged in an interdisciplinary research project that will investigate the relationship between genetics, structural alterations in the brain, and neurobehavioural outcomes in children impacted by FASD.

Resources

Powerpoint Presentations

Presenters

  • Dr. Gail Andrew MD, MDCM FRCP(C), Site Lead Paediatrics and Medical Director of FASD Services, Glenrose Rehabilitation Hospital, and Clinical Professor, University of Alberta, Edmonton, Alberta
    Dr. Andrew is a paediatrician at the Glenrose Rehabilitation Hospital, whose main interest has been in the area of developmental, learning,behavioural and emotional challenges of children, including those with known risk factors of prematurity, prenatal exposure to alcohol and adverse life experiences 
    such as maltreatment. She has a major interest in all aspects of Fetal Alcohol Spectrum Disorder, including prevention, diagnostic assessments, interventions and support of individuals with FASD and their caregivers. Dr. Andrew is also the co-chair of the Knowledge Translation and Exchange committee of the Canadian Network of Child and Youth Rehabilitation Centres and was awarded the Queen Elizabeth II Diamond Jubilee Medal for her contributions to FASD in Canada.
  • Dr. Carmen Rasmussen PhD, Assistant Professor, Section of Pediatric Neurosciences, Department of Pediatrics, University of Alberta, Edmonton, Alberta
    Carmen Rasmussen (PhD in Developmental Psychology) is an Assistant Professor in the Department of Pediatrics at the University of Alberta and a Research Affiliate at the Glenrose Rehabilitation Hospital, in Edmonton, Alberta. She researches neurobehavioral functioning in children with FASD.

  • Dr. James Reynolds, PhD, Professor, Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario
    Dr. Reynolds is a graduate of Queen’s University (B.Sc., 1982, Ph.D, 1987). After obtaining his doctorate, he completed postdoctoral training at the Addiction Research Foundation and the University of Toronto. Dr. Reynolds’ research interests over the past 20 years have centred around studies on the effects of alcohol on brain function. In particular, his current research program is focused on understanding the mechanisms of brain injury, and the resulting behavioural and cognitive deficits, that are induced by prenatal exposure to alcohol. Dr. Reynolds has been funded by CIHR for interdisciplinary basic and clinical investigations into the cellular mechanisms and neurobehavioural consequences of Fetal Alcohol Spectrum Disorder (FASD). He led a 7-member CIHR-funded New Emerging Team in FASD research, and is the Project Lead for the FASD Demonstration Project in NeuroDevNet. As the Project Lead, Dr. Reynolds co-ordinates multi-centre, cross-Canada projects encompassing basic science and clinical studies in FASD that involve genetics, brain imaging, neurobehavioural assessments and intervention studies.  More Information: http://www.neurodevnet.ca/
Created by Doug Maynard on 2012/11/16 21:07